Patent details

EP0687300 Title: LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION

Basic Information

Publication number:
EP0687300
PCT Application Number:
PCT/IB/94/00043
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP949092704
PCT Publication Number:
WO/94/20619
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION
French Title of Invention:
ANTICORPS LO-CD2a ET SES UTILISATIONS DANS L'INHIBITION DE L'ACTIVATION ET DE LA PROLIFERATION DES LYMPHOCYTES T
German Title of Invention:
LO-CD2A ANTIKÖRPER UND DESSEN VERWENDUNG ZUR INHIBITION VON T-ZELL-AKTIVIERUNG UND -WACHSTUM
SPC Number:

Dates

Filing date:
04/03/1994
Grant date:
12/09/2001
EP Publication Date:
12/09/2001
PCT Publication Date:
15/09/1994
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/12/1995
EP B1 Publication Date:
12/09/2001
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/03/2011
Expiration date:
04/03/2014
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/03/1994
 
 

Name:
UNIVERSITE CATHOLIQUE DE LOUVAIN
Address:
1, Place de l'Université, 1348 Louvain la Neuve, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/11/2001
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LATINNE Dominique
Address:
Belgium (BE)

2

Name:
BAZIN Hervé
Address:
Belgium (BE)

Priority

1

Priority Number:
27008
Priority Date:
05/03/1993
Priority Country:
United States (US)

2

Priority Number:
119032
Priority Date:
09/09/1993
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/13;
Filing date Document type Number of pages